MedPharm || طبصيدلة
الذهاب إلى القناة على Telegram
شرح مادة الصيدلة السريرية clinical pharmacology 🧑🏻⚕️ معرف التلي: mohammedsalim10 Instagram: _a1mh
إظهار المزيدلم يتم تحديد البلدالفئة غير محددة
3 508
المشتركون
لا توجد بيانات24 ساعات
-147 أيام
-5830 أيام
أرشيف المشاركات
3 508
T.R is 66 years old male with, Memory loss, Aphasia, Apraxia, Agnosia, depression, psychotic symptoms, aggression, motor hyperactivity, her MMSE was 7. What is the best treatment option for this case?
3 508
One of the diagnostic features of Alzheimer's disease is inability to perform learned (familiar) movements on command, this is called
3 508
In Alzheimer management, we need MRI at baseline, prior to 7th and 12th doses to identify brain edema, microhemorrhage, superficial siderosis, which drug needed this procedure?
3 508
All patients receiving treatment for Alzheimer disease should be monitored for therapeutic outcomes. The following parameter(s) should be monitored
3 508
Ahmed is a 65 years old man with severe Alzheimer disease. The suitable cholinesterase inhibitor is
3 508
In the diagnosis of AD, The Falstein Mini-Mental State Examination (MMSE) can help establish a history of deficits in two or more areas of cognition at baseline against. Which to evaluate change in severity over time, which statement is correct:
3 508
63 years old man with Alzheimer disease treated with Cholinesterase inhibitor.Which statement is correct?
a- No comparative trials have assessed the effectiveness of one agent over another
b-Donepezil, rivastigmine, and galantamine are indicated in severe AD.
c-donepezil is also indicated for mild-to-moderate AD
d-Mini-Mental State Examination MMSE is practical to use in the clinical setting to measure changes in cognitive function. Successful treatment would show a decline in MMSE score of less than 4 points per year.
e-The three cholinesterase inhibitors have similar efficacy in mild-to-moderate AD, and duration of benefit lasts 3-24 weeks
3 508
Regarding treatment of Alzheimer disease. Which one of the following drugs is considered drug of choice for Parkinson disease with dementia?
3 508
Ahmed's grandfather was diagnosed with mild Alzheimer Disease (AD). This medication cannot be indicated for mild AD:
3 508
About Alzheimer disease clinical presentation, which of the following symptom is NOT commonly associated with Alzheimer disease?
3 508
F.A is 71 years old Female with, Agnosia, depression, psychotic symptoms, aggression, motor hyperactivity, Memory loss, Aphasia, Apraxia, her MMSE was 6. She was started on her treatment and followed up by her doctor. While monitoring F.A during the course of the disease, Successful treatment would show a decline in MMSE score of:
3 508
5.U is 45 years old man with Alzheimer disease who is stable on galantamine, he is hypertensive with alcoholic liver cirrhosis and has positive family history for Alzheimer disease. One of the following is not a risk factor for Alzheimer's disease
3 508
Concerning pharmacological therapy of non-cognitive symptoms of Alzheimer disease, all of the treatments correct EXCEPT
3 508
The cholinesterase inhibitor drug that can be taken when an Alzheimer patient's condition is classified as severe is:
3 508
All of the following are considered cognitive symptoms of Alzheimer's disease, with the exception of:
